Hannah Goulart, Marina Konopleva, Nitin Jain, Naval Guastad Daver, Courtney Denton DiNardo, Tapan M. Kadia, Farhad Ravandi-Kashani, Yesid Alvarado, Fadi Haddad, Koichi Takahashi, Gautam Borthakur, Sherry Pierce, Susan Wahl, Allison Pike, Elias Jabbour, Sanam Loghavi, Muzaffar H. Qazilbash, Guillermo Garcia-Manero, Naveen Pemmaraju. "A phase II trial of tagraxofusp, hyper-CVAD, and venetoclax for patients with newly diagnosed or relapsed/refractory BPDCN.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6502